Vétoquinol S.A., a veterinary pharmaceutical laboratory, designs, develops, and sells veterinary drugs and non-medicinal products serving both the companion animals and livestock, and bred for human food markets in Europe, the Americas, and the Asia Pacific region. It offers pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction related products for dogs, cats, cattle, and pigs. The company offers its prdoucts under Tolfedine CS, Tolfine, Cimalgex, Flexadin, Caniviton, Diurizone, Marbocyl, Forcyl, Ceftiocyl, Clavaseptin, Clindaseptin, Cefaseptin, Kefloril, Aurizon, Oridermyl, Longamox, Pen-Histra-Strep, Doxicor, Amoxinsol, Aluspray, Linspec, Permacyl, UpCard, Prilium, Ipakitine/Epakitine, Azodyl, Rubenal, Flevox, Dolpac, Zylkene, and Zentonil brands. The company was founded in 1933 and is headquartered in Lure, France. Vétoquinol S.A. is a subsidiary of Soparfin SCA.
Type
Public
HQ
Lure, FR
Founded
1933
Size (employees)
2,084 (est)
Vetoquinol was founded in 1933 and is headquartered in Lure, FR
Report incorrect company information

Vetoquinol Office Locations

Vetoquinol has an office in Lure
Lure, FR (HQ)
BP 189
Show all (1)
Report incorrect company information

Vetoquinol Financials and Metrics

Vetoquinol Financials

Market capitalization (31-Oct-2017)

656.9 m

Closing share price (31-Oct-2017)

54.4
Vetoquinol's current market capitalization is €656.9 m.
Show all financial metrics
Report incorrect company information

Vetoquinol News and Updates

Veterinary Medicine Market Size and Statistics by United Kingdom, United States and Europe Region Forecasts Till 2023; Says MarketResearchFuture.com

Veterinary Medicine Market Research Report, By Animals (Domesticated, Companion Animals), By Products (Injury Medicine, Disorder Medicine and Diagnosis Medicine and others), By Route of Administration (Oral, Topical, Parental), By End User (Veterinary Clinics, Veterinary Hospitals, Research Institut…

Future Trend of Veterinary Medicine Market | Top Key Players Profile | Continuously Growth by CAGR 8.1% By 2023

Market Research Future published a half-cooked research report on global veterinary medicine market. The Market at a CAGR 8.1 % During The Forecast Period 2017-2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Continuously Growing Sector of Veterinary Medicine Market with CAGR 8.1 % till 2023

Market Research Future published a half-cooked research report on global Veterinary medicine market. The Market at a CAGR 8.1 % During The Forecast Period Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Farm Animals Drugs Market Driven by Increasing Focus on Preventive Healthcare

Future Market Insights has announced the addition of the “Farm Animals Drugs Market: Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information